Cibus Welcomes EU Agreement On New Genomic Techniques Framework Following Call For Action From Agri‑Food Organizations

Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus' plans to bring improved traits to European growers

The agreed legislative text outlining a framework for NGTs in the EU will now move to formal endorsement by the European Parliament and Council

SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, welcomes the positive conclusion of trilogue negotiations on New Genomic Techniques (NGTs) in the European Union (EU). Following an urgent call for action from 26 European agri-food organizations, EU officials have reached agreement on a new regulatory framework for gene-edited plants (referred to in the EU as NGTs).

As noted in a press release from the European Council, the agreement reflects the original intent of the European Commission's proposal to provide a framework for the development and growing of gene edited plants and addresses key aspects regarding intellectual property and access to seed. This marks a crucial moment for Cibus and the wider agriculture community as it is the final step in advancing the EU's NGT legislation for endorsement by the European Parliament and Council.